Role of ABC transporters in the chemoresistance of human gliomas

被引:57
作者
Decleves, Xavier
Amiel, Alexandra
Delattre, Jean-Yves
Scherrmann, Jean-Michel
机构
[1] INSERM, U705, CNRS, UMR 7157,Lab Neuropsychopharmacol,Fac Pharm, F-75006 Paris, France
[2] Hop Fernand Widal, INSERM, U705, F-75475 Paris 10, France
[3] Univ Paris 05, F-75270 Paris 06, France
[4] Univ Paris 07, F-75221 Paris 05, France
[5] CHU Pitie Salpetriere, Dept Neurooncol Mazarin, Paris, France
[6] Hop Hotel Dieu, Dept Pharm, Toxicol Lab, F-75181 Paris, France
关键词
ABC transporters; astrocytes; glioma; chemoresistance;
D O I
10.2174/156800906777723930
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Malignant gliomas are frequently chemoresistant and this resistance seems to depend on at least two mechanisms. First, the poor penetration of many anticancer drugs across the blood-brain barrier (BBB), the blood-cerebrospinal fluid barrier (BCSFB) and blood-tumor barrier (BTB), due to their interaction with several ATP-binding cassette (ABC) drug efflux transporters that are overexpressed by the endothelial or epithelial cells of these barriers. Second, resistance may involve the tumor cells themselves. Although ABC drug efflux transporters in tumor cells confer multidrug resistance (MDR) on several other solid tumors, their role in gliomas is unclear. This review focuses on astrocytes and summarizes the current state of knowledge about the expression, distribution and function of ABC transporters in normal and tumor astroglial cells. The recognition of anticancer drugs by ABC transporters in astroglial cells and their participation in the multidrug resistance phenotype of human gliomas is discussed.
引用
收藏
页码:433 / 445
页数:13
相关论文
共 119 条
[1]   CHEMOSENSITISATION OF SPONTANEOUS MULTIDRUG-RESISTANCE BY A 1,4-DIHYDROPYRIDINE ANALOG AND VERAPAMIL IN HUMAN GLIOMA CELL-LINES OVEREXPRESSING MRP OR MDR1 [J].
ABE, T ;
KOIKE, K ;
OHGA, T ;
KUBO, T ;
WADA, M ;
KOHNO, K ;
MORI, T ;
HIDAKA, K ;
KUWANO, M .
BRITISH JOURNAL OF CANCER, 1995, 72 (02) :418-423
[2]   Expression of multidrug resistance protein gene in patients with glioma after chemotherapy [J].
Abe, T ;
Mori, T ;
Wakabayashi, Y ;
Nakagawa, M ;
Cole, SPC ;
Koike, K ;
Kuwano, M ;
Hori, S .
JOURNAL OF NEURO-ONCOLOGY, 1998, 40 (01) :11-18
[3]  
ABE T, 1994, INT J CANCER, V58, P860
[4]  
Afra D, 2002, LANCET, V359, P1011
[5]  
Andersson U, 2004, CLIN NEUROPATHOL, V23, P21
[6]   Localization of breast cancer resistance protein (BCRP) in microvessel endothelium of human control and epileptic brain [J].
Aronica, E ;
Gorter, JA ;
Redeker, S ;
van Vliet, EA ;
Ramkema, M ;
Scheffer, GL ;
Scheper, RJ ;
van der Valk, P ;
Leenstra, S ;
Baayen, JC ;
Spliet, WGM ;
Troost, D .
EPILEPSIA, 2005, 46 (06) :849-857
[7]   Expression and cellular distribution of multidrug resistance-related proteins in the hippocampus of patients with mesial temporal lobe epilepsy [J].
Aronica, E ;
Gorter, JA ;
Ramkema, M ;
Redeker, S ;
Özbas-Gerçeker, F ;
van Vliet, EA ;
Scheffer, GL ;
Scheper, RJ ;
van der Valk, P ;
Baayen, JC ;
Troost, D .
EPILEPSIA, 2004, 45 (05) :441-451
[8]   Expression and cellular distribution of multidrug transporter proteins in two major causes of medically intractable epilepsy: Focal cortical dysplasia and glioneuronal tumors [J].
Aronica, E ;
Gorter, JA ;
Jansen, GH ;
Van Veelen, CWM ;
Van Rijen, PC ;
Leenstra, S ;
Ramkema, M ;
Scheffer, GL ;
Scheper, RJ ;
Troost, D .
NEUROSCIENCE, 2003, 118 (02) :417-429
[9]   Does P-glycoprotein play a role in clinical resistance of malignant astrocytoma? [J].
Ashmore, SM ;
Thomas, DGT ;
Darling, JL .
ANTI-CANCER DRUGS, 1999, 10 (10) :861-872
[10]   Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme [J].
Athanassiou, H ;
Synodinou, M ;
Maragoudakis, E ;
Paraskevaidis, M ;
Verigos, C ;
Misailidou, D ;
Antonadou, D ;
Saris, G ;
Beroukas, K ;
Karageorgis, P .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (10) :2372-2377